Omega Therapeutics pulls in $126m Series C

Omega Therapeutics Inc, a biotechnology company, has secured $126 million in Series C financing.

Omega Therapeutics Inc, a biotechnology company, has secured $126 million in Series C financing. The lead investor was Flagship Pioneering.

Source: Press Release